News & Events

Clinical Program BL8040

Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE

BioLineRx Announces Updated Phase 2a […]

BioLineRx Presents Preclinical Data From Triple Combination of BL-8040

BioLineRx Presents Preclinical Data From […]

BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients

TEL AVIV, Israel, March 27, 2019 /PRNewswire/ […]

BioLineRx Increases Stake in BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications

Transaction increases BioLineRx’s stake by […]

Pre-Clinical Program

Biokine Announces Issuance of European Patent

Biokine Therapeutics Announces Issuance of […]

Biokine Announces Issuance of Mexican Patent

Biokine Therapeutics Announces Issuance of […]

Biokine Therapeutics Announces Issuance of United States Patent covering the composition and use of peptides for inhibiting chemokine binding to chemokine receptors

Biokine Therapeutics Announces Issuance of […]

Biokine Therapeutics Announces Issuance of Japanese Patent covering the composition and use of polypeptides

Biokine Therapeutics Announces Issuance of […]